Alivecor gets a green light from FDA to screen for dangerously high potassium levels in the blood

The U.S. Food and Drug Administration has granted AliveCor the designation of ‘breakthrough device’ for it’s ability to detect a rare but dangerous blood condition called hyperkalemia without taking any blood from the patient. Hyperkalemia is a medical term describing elevated potassium levels in the blood and is usually found in those with kidney disease. […]

View More Alivecor gets a green light from FDA to screen for dangerously high potassium levels in the blood